Delivery Order 36C24525D0052-36C24526N0404
- Not listed
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a $322,968.95 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 for the supply of radiopharmaceutical products. The award, issued on December 12, 2025, with a completion date of December 11, 2026, does not include a set-aside designation and represents a call against an existing Indefinite Delivery Vehicle. Performance will take...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $356,461.75 by the Department of Veterans Affairs Veterans Integrated Service Network 5 for the supply of radiopharmaceuticals. The contract, awarded on April 1, 2025, carries a firm fixed price structure and an ultimate completion date of March 31, 2026. Performance will be executed from the contractor's facility in Lake Mary, Florida. This delivery order does not carry a set-aside designation and...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 17 awarded a $990,211 delivery order for radiopharmaceuticals to RLS (USA) Inc., a foreign-owned radiopharmacy company specializing in nuclear medicine products for federal healthcare agencies. The contract employs firm fixed pricing and is not designated as a set-aside. RLS (USA) Inc. will perform work at its facility in Lake Mary, Florida, with an ultimate completion date of September 17, 2026. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, received a $431,476 firm fixed-price delivery order from the Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) for cyclotron radiopharmaceuticals with a performance period from April 1, 2026 through March 31, 2027. This delivery order was awarded without a set-aside designation and represents a call against one of RLS (USA) Inc.'s existing Indefinite Delivery Vehicles with...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a delivery order to RLS (USA) Inc. for radiopharmaceutical base supply services with a ceiling value of $1.56 million, effective April 1, 2026 through March 31, 2027. This firm fixed-price delivery order was issued without set-aside designation and calls for performance at RLS's facility in Lake Mary, Florida. RLS (USA) Inc. is a foreign-owned radiopharmacy company specializing in the supply of...
- RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a delivery order valued at $250,075.29 by the Department of Veterans Affairs' Northern California Health Care System (Veterans Integrated Service Network 21) for radiopharmaceuticals and radiopharmaceutical supplies. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, utilizes firm fixed-price pricing and is not designated as a set-aside contract. This delivery order...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 on January 1, 2026, for the supply of radiopharmaceuticals for nuclear medicine patients. The contract carries a firm fixed-price ceiling value of $493,958.37 with an ultimate completion date of December 31, 2026, and will be performed in Lake Mary, Florida. This delivery order is not designated as a set-aside contract and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $882,014.09 by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 20 on March 1, 2020. The contract, which is set aside for 8(a) small businesses under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), calls for the supply of radiopharmaceuticals to support nuclear medicine diagnostic and therapeutic...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $1,747,515.93 by the Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), on March 1, 2026, for the supply of radiopharmaceuticals and nuclear medicine products. This unrestricted acquisition, with no set-aside designation, will support diagnostic imaging procedures at the Clement J. Zablocki VA Medical Center in...
- The Department of Veterans Affairs, through Veterans Integrated Service Network 22, awarded a $752,000 delivery order to RLS (USA) Inc. for radiopharmaceutical supply to VA medical facilities serving the Phoenix and Tucson regions. The contract employs a firm fixed-price delivery order structure under an indefinite delivery indefinite quantity (IDIQ) vehicle, with performance extending through March 31, 2027. No small business set-aside was utilized for this procurement. RLS (USA) Inc.,...
- 36C24525D0052Indefinite Delivery Contract
- 36C24525D0052-36C24526N0404Delivery Order
RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a firm fixed-price delivery order valued at $432,681.74 by Veterans Integrated Service Network 5 (VISN 5) for the supply of radiopharmaceutical products. The award, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, carries no set-aside designation and represents performance at the contractor's Lake Mary, Florida facility. This delivery order is issued under an existing Indefinite Delivery Vehicle (IDV) contract that RLS (USA) Inc. maintains with VA VISN 5, valued at $2,162,919.87 and extending through March 31, 2030, which enables the VA to procure radiopharmaceuticals on an as-needed basis without requiring separate competitive procurements. RLS (USA) Inc. serves as a critical supplier of medical isotopes and diagnostic imaging agents to the Department of Veterans Affairs and Defense Health Agency, operating 31 radiopharmacy facilities across 18 states to ensure efficient delivery of time-sensitive radiopharmaceutical products. The company supplies a comprehensive portfolio including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, iodine-123, iodine-131, indium-111, and specialized products such as Gallium-68 Dotatate (NETSPOT) and technetium-99m Sestamibi (Cardiolite), which are essential for diagnostic and therapeutic nuclear medicine procedures performed at VA medical centers and military treatment facilities nationwide. The contractor currently maintains multiple large IDVs across various VISN networks, establishing RLS (USA) Inc. as a preferred supplier within the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $432.7k | 3/30/26 |